Literature DB >> 27551426

Substrate Modulus Regulates Osteogenic Differentiation of Rat Mesenchymal Stem Cells through Integrin β1 and BMP Receptor Type IA.

R Guo1, S Lu1, A R Merkel2, J A Sterling3, S A Guelcher4.   

Abstract

Osteoblast differentiation of mesenchymal stem cells is regulated by both soluble factor (e.g., bone morphogenetic proteins (BMP)) and mechanically transduced signaling, but the mechanisms have only been partially elucidated. In this study, physical association of BMP Receptor I (BMPRI) with integrin β1 sub-unit (Iβ1) was hypothesized to mediate osteoblast differentiation of rat bone marrow-derived mesenchymal stem cells (MSCs) on bone-like substrates. The effects of substrate modulus on osteoblast differentiation of MSCs were investigated for 2D poly(ester urethane) films with moduli varying from 5 - 266 MPa, which spans the range from collagen fibrils to trabecular bone. SMAD1/5 and p44/42 MAPK signaling, expression of markers of osteoblast differentiation, and matrix mineralization increased with increasing substrate modulus. The effects of substrate modulus on osteoblast differentiation were mediated by Iβ1, which was also expressed at higher levels on increasingly rigid substrates. Förster resonance energy transfer (FRET) and immunoprecipitation (IP) experiments showed that physical association of Iβ1 and BMP Receptor I (BMRPRI) increased with substrate modulus, resulting in activation of the BMP signaling pathway. Thus, these studies showed that integrin and BMP signaling converge to regulate osteoblast differentiation of MSCs, which may potentially guide the design of scaffolds and rhBMP-2 delivery systems for bone regeneration.

Entities:  

Year:  2016        PMID: 27551426      PMCID: PMC4991780          DOI: 10.1039/C5TB02747K

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  45 in total

Review 1.  Tissue cells feel and respond to the stiffness of their substrate.

Authors:  Dennis E Discher; Paul Janmey; Yu-Li Wang
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

2.  Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation.

Authors:  Andrew S Rowlands; Peter A George; Justin J Cooper-White
Journal:  Am J Physiol Cell Physiol       Date:  2008-08-27       Impact factor: 4.249

3.  Synthesis and in vitro biocompatibility of injectable polyurethane foam scaffolds.

Authors:  Scott A Guelcher; Vishal Patel; Katie M Gallagher; Susan Connolly; Jonathan E Didier; John S Doctor; Jeffrey O Hollinger
Journal:  Tissue Eng       Date:  2006-05

Review 4.  Integrin and growth factor receptor crosstalk.

Authors:  B P Eliceiri
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

Review 5.  Stretchy proteins on stretchy substrates: the important elements of integrin-mediated rigidity sensing.

Authors:  Simon W Moore; Pere Roca-Cusachs; Michael P Sheetz
Journal:  Dev Cell       Date:  2010-08-17       Impact factor: 12.270

6.  Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.

Authors:  Yu-Ru V Shih; Kuo-Fung Tseng; Hsiu-Yu Lai; Chi-Hung Lin; Oscar K Lee
Journal:  J Bone Miner Res       Date:  2011-04       Impact factor: 6.741

7.  Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report.

Authors:  Sreevathsa Boraiah; Omesh Paul; David Hawkes; Matthew Wickham; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2009-08-20       Impact factor: 4.176

8.  ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK.

Authors:  Chirag B Khatiwala; Peter D Kim; Shelly R Peyton; Andrew J Putnam
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

Review 9.  Mesenchymal stem cells for bone repair and metabolic bone diseases.

Authors:  Anita H Undale; Jennifer J Westendorf; Michael J Yaszemski; Sundeep Khosla
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

10.  The regulation of osteogenesis by ECM rigidity in MC3T3-E1 cells requires MAPK activation.

Authors:  Chirag B Khatiwala; Shelly R Peyton; Mark Metzke; Andrew J Putnam
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

View more
  5 in total

1.  Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease.

Authors:  Joseph P Vanderburgh; Kristin A Kwakwa; Thomas A Werfel; Alyssa R Merkel; Mukesh K Gupta; Rachelle W Johnson; Scott A Guelcher; Craig L Duvall; Julie A Rhoades
Journal:  J Control Release       Date:  2019-09-05       Impact factor: 9.776

2.  Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction.

Authors:  Joseph Vanderburgh; Jordan L Hill; Mukesh K Gupta; Kristin A Kwakwa; Sean K Wang; Kathleen Moyer; Sean K Bedingfield; Alyssa R Merkel; Richard d'Arcy; Scott A Guelcher; Julie A Rhoades; Craig L Duvall
Journal:  ACS Nano       Date:  2020-01-08       Impact factor: 15.881

3.  Settable polymer/ceramic composite bone grafts stabilize weight-bearing tibial plateau slot defects and integrate with host bone in an ovine model.

Authors:  Sichang Lu; Madison A P McGough; Stefanie M Shiels; Katarzyna J Zienkiewicz; Alyssa R Merkel; Joseph P Vanderburgh; Jeffry S Nyman; Julie A Sterling; David J Tennent; Joseph C Wenke; Scott A Guelcher
Journal:  Biomaterials       Date:  2018-06-26       Impact factor: 12.479

Review 4.  A glance on the role of actin in osteogenic and adipogenic differentiation of mesenchymal stem cells.

Authors:  Asmat Ullah Khan; Rongmei Qu; Tingyu Fan; Jun Ouyang; Jingxing Dai
Journal:  Stem Cell Res Ther       Date:  2020-07-16       Impact factor: 6.832

5.  3D Bone Morphology Alters Gene Expression, Motility, and Drug Responses in Bone Metastatic Tumor Cells.

Authors:  Ushashi C Dadwal; Alyssa R Merkel; Jonathan M Page; Kristin A Kwakwa; Michael Kessler; Julie A Rhoades
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.